Literature DB >> 22006856

Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutations.

Christoph Neumann-Haefelin1, Cesar Oniangue-Ndza, Thomas Kuntzen, Julia Schmidt, Katja Nitschke, John Sidney, Célia Caillet-Saguy, Marco Binder, Nadine Kersting, Michael W Kemper, Karen A Power, Susan Ingber, Laura L Reyor, Kelsey Hills-Evans, Arthur Y Kim, Georg M Lauer, Volker Lohmann, Alessandro Sette, Matthew R Henn, Stéphane Bressanelli, Robert Thimme, Todd M Allen.   

Abstract

UNLABELLED: Human leukocyte antigen B27 is associated with spontaneous viral clearance in hepatitis C virus (HCV) infection. Viral escape within the immunodominant, HLA-B27-restricted, HCV-specific, cluster of differentiation (CD)8(+) T-cell epitope, nonstructural protein (NS)5B(2841-2849) (ARMILMTHF), has been shown to be limited by viral fitness costs as well as broad T-cell cross-recognition, suggesting a potential mechanism of protection by HLA-B27. Here, we studied the subdominant HLA-B27-restricted epitope, NS5B(2936-2944) (GRAAICGKY), to further define the mechanisms of protection by HLA-B27. We identified a unique pattern of escape mutations within this epitope in a large cohort of HCV genotype 1a-infected patients. The predominant escape mutations represented conservative substitutions at the main HLA-B27 anchor residue or a T-cell receptor contact site, neither of which impaired viral replication capacity, as assessed in a subgenomic HCV replicon system. In contrast, however, in a subset of HLA-B27(+) subjects, rare escape mutations arose at the HLA-B27 anchor residue, R(2937) , which nearly abolished viral replication. Notably, these rare mutations only occurred in conjunction with the selection of two equally rare, and structurally proximal, upstream mutations. Coexpression of these upstream mutations with the rare escape mutations dramatically restored viral replication capacity from <5% to ≥ 70% of wild-type levels.
CONCLUSION: The selection of rare CTL escape mutations in this HLA-B27-restricted epitope dramatically impairs viral replicative fitness, unless properly compensated. These data support a role for the targeting of highly constrained regions by HLA-B27 in its ability to assert immune control of HCV and other highly variable pathogens.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22006856      PMCID: PMC3201753          DOI: 10.1002/hep.24541

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  25 in total

Review 1.  The impact of the M184V substitution on drug resistance and viral fitness.

Authors:  Mark A Wainberg
Journal:  Expert Rev Anti Infect Ther       Date:  2004-02       Impact factor: 5.091

2.  HLA-B27: a registry of constitutive peptide ligands.

Authors:  J A Lopez de Castro; I Alvarez; M Marcilla; A Paradela; M Ramos; L Sesma; M Vázquez
Journal:  Tissue Antigens       Date:  2004-05

3.  Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution.

Authors:  Christoph Neumann-Haefelin; Susan McKiernan; Scott Ward; Sergei Viazov; Hans Christian Spangenberg; Thomas Killinger; Thomas F Baumert; Natalja Nazarova; Isabelle Sheridan; Oliver Pybus; Fritz von Weizsäcker; Michael Roggendorf; Dermot Kelleher; Paul Klenerman; Hubert E Blum; Robert Thimme
Journal:  Hepatology       Date:  2006-03       Impact factor: 17.425

4.  Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source.

Authors:  Susan M McKiernan; Richard Hagan; Michael Curry; George S A McDonald; Alan Kelly; Niamh Nolan; Anne Walsh; John Hegarty; Emer Lawlor; Dermot Kelleher
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

5.  High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection.

Authors:  Georg M Lauer; Eleanor Barnes; Michaela Lucas; Joerg Timm; Kei Ouchi; Arthur Y Kim; Cheryl L Day; Gregory K Robbins; Deborah R Casson; Markus Reiser; Geoffrey Dusheiko; Todd M Allen; Raymond T Chung; Bruce D Walker; Paul Klenerman
Journal:  Gastroenterology       Date:  2004-09       Impact factor: 22.682

6.  Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection.

Authors:  Hayley Crawford; Julia G Prado; Alasdair Leslie; Stéphane Hué; Isobella Honeyborne; Sharon Reddy; Mary van der Stok; Zenele Mncube; Christian Brander; Christine Rousseau; James I Mullins; Richard Kaslow; Paul Goepfert; Susan Allen; Eric Hunter; Joseph Mulenga; Photini Kiepiela; Bruce D Walker; Philip J R Goulder
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

7.  A comprehensive structure-function comparison of hepatitis C virus strain JFH1 and J6 polymerases reveals a key residue stimulating replication in cell culture across genotypes.

Authors:  Melanie Schmitt; Nathalie Scrima; Danijela Radujkovic; Célia Caillet-Saguy; Philip C Simister; Peter Friebe; Oliver Wicht; Rahel Klein; Ralf Bartenschlager; Volker Lohmann; Stéphane Bressanelli
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

8.  Immune evasion versus recovery after acute hepatitis C virus infection from a shared source.

Authors:  Ian Tester; Susan Smyk-Pearson; Ping Wang; Anne Wertheimer; Ermei Yao; David M Lewinsohn; John E Tavis; Hugo R Rosen
Journal:  J Exp Med       Date:  2005-06-06       Impact factor: 14.307

9.  Cellular immune selection with hepatitis C virus persistence in humans.

Authors:  Andrea L Cox; Timothy Mosbruger; Qing Mao; Zhi Liu; Xiao-Hong Wang; Hung-Chih Yang; John Sidney; Alessandro Sette; Drew Pardoll; David L Thomas; Stuart C Ray
Journal:  J Exp Med       Date:  2005-06-06       Impact factor: 14.307

10.  Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees.

Authors:  Jens Bukh; Thomas Pietschmann; Volker Lohmann; Nicole Krieger; Kristina Faulk; Ronald E Engle; Sugantha Govindarajan; Max Shapiro; Marisa St Claire; Ralf Bartenschlager
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

View more
  24 in total

Review 1.  Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells.

Authors:  Barbara Rehermann
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

2.  Statistical linkage analysis of substitutions in patient-derived sequences of genotype 1a hepatitis C virus nonstructural protein 3 exposes targets for immunogen design.

Authors:  Ahmed A Quadeer; Raymond H Y Louie; Karthik Shekhar; Arup K Chakraborty; I-Ming Hsing; Matthew R McKay
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

Review 3.  An update on the contribution of the MHC to AS susceptibility.

Authors:  John D Reveille
Journal:  Clin Rheumatol       Date:  2014-05-18       Impact factor: 2.980

Review 4.  An Update on the Genetic Polymorphism of HLA-B*27 With 213 Alleles Encompassing 160 Subtypes (and Still Counting).

Authors:  Muhammad A Khan
Journal:  Curr Rheumatol Rep       Date:  2017-02       Impact factor: 4.592

5.  Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8+ T Cells.

Authors:  Hadi Karimzadeh; Muthamia M Kiraithe; Anna D Kosinska; Manuel Glaser; Melanie Fiedler; Valerie Oberhardt; Elahe Salimi Alizei; Maike Hofmann; Juk Yee Mok; Melanie Nguyen; Wim J E van Esch; Bettina Budeus; Jan Grabowski; Maria Homs; Antonella Olivero; Hossein Keyvani; Francisco Rodríguez-Frías; David Tabernero; Maria Buti; Andreas Heinold; Seyed Moayed Alavian; Tanja Bauer; Julian Schulze Zur Wiesch; Bijan Raziorrouh; Daniel Hoffmann; Antonina Smedile; Mario Rizzetto; Heiner Wedemeyer; Jörg Timm; Iris Antes; Christoph Neumann-Haefelin; Ulrike Protzer; Michael Roggendorf
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

Review 6.  Hepatitis C virus: Is it time to say goodbye yet? Perspectives and challenges for the next decade.

Authors:  Heidi Barth
Journal:  World J Hepatol       Date:  2015-04-18

Review 7.  Progress in the development of vaccines for hepatitis C virus infection.

Authors:  Faezeh Ghasemi; Sina Rostami; Zahra Meshkat
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 8.  Emerging concepts in immunity to hepatitis C virus infection.

Authors:  Hugo R Rosen
Journal:  J Clin Invest       Date:  2013-10-01       Impact factor: 14.808

9.  Compensatory mutations restore the replication defects caused by cytotoxic T lymphocyte escape mutations in hepatitis C virus polymerase.

Authors:  Cesar Oniangue-Ndza; Thomas Kuntzen; Michael Kemper; Andrew Berical; Yaoyu E Wang; Christoph Neumann-Haefelin; Peter Kristian Foote; Kelsey Hills-Evans; Laura L Reyor; Katherine Kane; Adrianne D Gladden; Allyson K Bloom; Karen A Power; Robert Thimme; Georg M Lauer; Matthew R Henn; Arthur Y Kim; Todd M Allen
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

10.  HLA-B*27 subtype specificity determines targeting and viral evolution of a hepatitis C virus-specific CD8+ T cell epitope.

Authors:  Katja Nitschke; Alejandro Barriga; Julia Schmidt; Jörg Timm; Sergei Viazov; Thomas Kuntzen; Arthur Y Kim; Georg M Lauer; Todd M Allen; Silvana Gaudieri; Andri Rauch; Christian M Lange; Christoph Sarrazin; Thomas Eiermann; John Sidney; Alessandro Sette; Robert Thimme; Daniel López; Christoph Neumann-Haefelin
Journal:  J Hepatol       Date:  2013-08-23       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.